Cargando…
NLRP3-Mediated Inflammation in Atherosclerosis and Associated Therapeutics
The NLRP3 inflammasome is a crucial constituent of the body’s innate immune system, and a multiprotein platform which is initiated by pattern recognition receptors (PRRs). Its activation leads to caspase-1 maturation and release of inflammatory cytokines, interleukin-1β (IL-1β) and IL-18, and subseq...
Autores principales: | Lu, Na, Cheng, Weijia, Liu, Dongling, Liu, Gang, Cui, Can, Feng, Chaoli, Wang, Xianwei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9045366/ https://www.ncbi.nlm.nih.gov/pubmed/35493086 http://dx.doi.org/10.3389/fcell.2022.823387 |
Ejemplares similares
-
α1-nAchR-Mediated Signaling Through Lipid Raft Is Required for Nicotine-Induced NLRP3 Inflammasome Activation and Nicotine-Accelerated Atherosclerosis
por: Duan, Fengqi, et al.
Publicado: (2021) -
Gasdermin D Mediates Inflammation-Induced Defects in Reverse Cholesterol Transport and Promotes Atherosclerosis
por: Opoku, Emmanuel, et al.
Publicado: (2021) -
Blockade of Macrophage CD147 Protects Against Foam Cell Formation in Atherosclerosis
por: Lv, Jian-Jun, et al.
Publicado: (2021) -
Non-coding RNAs are key players and promising therapeutic targets in atherosclerosis
por: Yu, Zhun, et al.
Publicado: (2023) -
NLRP3 Inflammasome: A Promising Therapeutic Target for Drug-Induced Toxicity
por: Wei, Shanshan, et al.
Publicado: (2021)